Lynryl Trio (10x10 T)

Composition

Glimepiride 2mg, Voglibose 0.2mg & Metformin 500mg (SR) Bilayered Tab

Lynryl TRIO Tablets are a combination of Glimepiride, Voglibose, and Metformin Hydrochloride (Sustained Release) formulated for the effective management of Type 2 Diabetes Mellitus. This triple-drug therapy helps achieve better glycemic control by targeting multiple mechanisms involved in blood sugar regulation.

Key Benefits

- Helps maintain optimal blood glucose levels throughout the day.

- Reduces post-meal blood sugar spikes by delaying carbohydrate absorption.

- Improves insulin secretion and insulin sensitivity.

- Sustained-release formulation provides prolonged glucose control.

- Supports long-term diabetes management when combined with a balanced diet and regular exercise.